Form 4 for TNGX Tango Therapeutics, Inc.
Accepted 2026-06-23 18:10:39 ET · period of report 2026-06-19 · accession 0001193125-26-279871 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 18:10 | 2026-06-19 | TNGX | Azelby Robert | Dir | A - Grant | $0.00 | +5,740 | 5,740 | New | $0 |
| D | 2026-06-23 18:10 | 2026-06-19 | TNGX | Azelby Robert | Dir | A - Grant | $0.00 | +35.9K | 35.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-19 | A | A | 5,740 | $0.00 | 5,740 | D | — | — | (F1) These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-19 | A | A | 35,910 | $0.00 | 35,910 | D | $27.97 · — to 2036-06-19 | 35,910 Common Stock | (F2) This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |